Dipeptidyl Peptidase-4 inhibitors and the risk of bullous pemphigoid among patients with type 2 diabetes: A population-based cohort study

被引：0
|
作者：
Douros, Antonios [1 ,2 ,3 ]
Rouette, Julie [1 ]
Yin, Hui [3 ]
Yu, Oriana Hoi Yun [3 ]
Filion, Kristian B. [1 ,3 ]
Azoulay, Laurent [1 ,3 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Lady Davis Inst, Montreal, PQ, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
458
引用
收藏
页码：225 / 226
页数：2
相关论文
共 50 条
  • [1] Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study
    Wu, Chen-Yi
    Wu, Chun-Ying
    Li, Chung-Pin
    Chou, Yiing-Jenq
    Lin, Yi-Hsian
    Chang, Yun-Ting
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 171
  • [2] Dipeptidyl peptidase-4 inhibitors and the risk of bullous pemphigoid among patients with type 2 diabetes
    Rouette, Julie
    Douros, Antonios
    Yin, Hui
    Yu, Oriana Hoi Yun
    Filion, Kristian B.
    Azoulay, Laurent
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB47 - AB47
  • [3] Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: Population-based cohort study
    Pradhan, Richeek
    Azoulay, Laurent
    Platt, Robert W.
    Yu, Oriana H. Y.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 13 - 13
  • [4] Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes
    Douros, Antonios
    Rouette, Julie
    Yin, Hui
    Yu, Oriana Hoi Yun
    Filion, Kristian B.
    Azoulay, Laurent
    [J]. DIABETES CARE, 2019, 42 (08) : 1496 - 1503
  • [5] Dipeptidyl Peptidase-4 Inhibitors and the Risk of Pancreatitis in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study
    Kim, Young-Gun
    Kim, Seirhan
    Han, Seung Jin
    Kim, Dae Jung
    Lee, Kwan-Woo
    Kim, Hae Jin
    [J]. JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [6] Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study
    Pradhan, Richeek
    Yu, Oriana H. Y.
    Platt, Robert W.
    Azoulay, Laurent
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2023, 11 (06)
  • [7] Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study
    Shapiro, Samantha
    Yin, Hui
    Yu, Oriana
    Azoulay, Laurent
    [J]. DRUG SAFETY, 2024, 47 (08) : 759 - 769
  • [8] Dipeptidyl peptidase-4 inhibitors and risk of diabetic retinopathy progression in patients with type 2 diabetes: a population-based cohort study
    Chung, Y. R.
    Ha, K. H.
    Kim, D. J.
    Lee, K.
    [J]. ACTA OPHTHALMOLOGICA, 2018, 96 : 23 - 23
  • [9] Dipeptidyl Peptidase-4 Inhibitors and the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes in Taiwan A Population-Based Cohort Study
    Lai, Yun-Ju
    Hu, Hsiao-Yun
    Chen, Hsin-Hua
    Chou, Pesus
    [J]. MEDICINE, 2015, 94 (43)
  • [10] Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus A Population-Based Cohort Study
    Kim, Young-Gun
    Yoon, Dukyong
    Park, Sooyoung
    Han, Seung Jin
    Kim, Dae Jung
    Lee, Kwan-Woo
    Park, Rae Woong
    Kim, Hae Jin
    [J]. CIRCULATION-HEART FAILURE, 2017, 10 (09)
12345